Sr One Capital Management, LP Portfolio Holdings

Sr One Capital Management, LP

  • $269 Million
  • Q4 2024

Sr One Capital Management, LP has filed its 13F form on February 13, 2025 for Q4 2024 where it was disclosed a total value porftolio of $269 Million distributed in 11 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Arcellx, Inc. with a value of $179M, Crispr Therapeutics Ag with a value of $41.3M, Design Therapeutics, Inc. with a value of $40.3M, Nkarta, Inc. with a value of $8.3M, and Alumis Inc. with a value of $0.

Examining the 13F form we can see an decrease of $26.9M in the current position value, from $295M to 269M.

Below you can find more details about Sr One Capital Management, LP portfolio as well as his latest detailed transactions.

Portfolio value $269 Million
Healthcare: $269 Million

Stock Holdings Table Market Cap. of $300 Millions to $2 Billions

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History

Summary

  • Portfolio
  • No. of Stocks 11
  • Current Value $269 Million
  • Prior Value $295 Million
  • Filing
  • Period Q4 2024
  • Filing Date February 13, 2025
  • Form Type 13F-HR
  • Activity in Q4 2024
  • New Purchases 0 stocks
  • Additional Purchases 2 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 0 stocks
Track This Portfolio

Track Sr One Capital Management, LP Portfolio

Follow Sr One Capital Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sr One Capital Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Sr One Capital Management, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email